Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea
Abstract Eritrea is an East African multiethnic country with an intermediate endemicity for hepatitis B. Our aim was to establish the most prevalent genotypes of hepatitis B virus (HBV) among patients with liver disease. A total of 293 Eritrean patients with liver disease who were hepatitis B surfac...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0e15a3df3ec4269833fbf6db6030b56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f0e15a3df3ec4269833fbf6db6030b56 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f0e15a3df3ec4269833fbf6db6030b562021-12-02T17:50:57ZPrevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea10.1038/s41598-021-90836-w2045-2322https://doaj.org/article/f0e15a3df3ec4269833fbf6db6030b562021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90836-whttps://doaj.org/toc/2045-2322Abstract Eritrea is an East African multiethnic country with an intermediate endemicity for hepatitis B. Our aim was to establish the most prevalent genotypes of hepatitis B virus (HBV) among patients with liver disease. A total of 293 Eritrean patients with liver disease who were hepatitis B surface antigen (HBsAg) positive were enrolled. All sera were tested for liver transaminases, HBV DNA viral load, and hepatitis B seromarkers including HBsAg, anti-HBcAb (total), HBeAg, and anti-HBeAb. Those reactive for HBsAg and anti-HBc (total) were further tested for HBV genotyping. The median (interquartile range) of HBV DNA viral load and ALT levels were 3.47 (1.66) log IU/mL and 28 (15.3) IU/L, respectively. Using type-specific primer-based genotyping method, 122/293 (41.6%) could be genotyped. Irrespective of mode of occurrence, HBV genotype D (21.3%) was the predominant circulating genotype, followed by genotypes C (17.2%), E (15.6%), C/D (13.1%), and C/E (10.7%). Genotypes C/D/E (7.4%), A/D (4.9%), D/E (4.1%), A (2.5%), and B, A/E, B/E, and A/D/C (0.8%) were also present. HBV in Eritrea is comprised of a mixture of HBV genotypes. This is the first study of HBV genotyping among patients with liver disease in Eritrea.Mohammed Elfatih HamidaSaud Mohammed RajaYodahi PetrosMunir WahabYemane SeyoumIsam Mohammed ElkhidirFreweini TekleNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mohammed Elfatih Hamida Saud Mohammed Raja Yodahi Petros Munir Wahab Yemane Seyoum Isam Mohammed Elkhidir Freweini Tekle Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
description |
Abstract Eritrea is an East African multiethnic country with an intermediate endemicity for hepatitis B. Our aim was to establish the most prevalent genotypes of hepatitis B virus (HBV) among patients with liver disease. A total of 293 Eritrean patients with liver disease who were hepatitis B surface antigen (HBsAg) positive were enrolled. All sera were tested for liver transaminases, HBV DNA viral load, and hepatitis B seromarkers including HBsAg, anti-HBcAb (total), HBeAg, and anti-HBeAb. Those reactive for HBsAg and anti-HBc (total) were further tested for HBV genotyping. The median (interquartile range) of HBV DNA viral load and ALT levels were 3.47 (1.66) log IU/mL and 28 (15.3) IU/L, respectively. Using type-specific primer-based genotyping method, 122/293 (41.6%) could be genotyped. Irrespective of mode of occurrence, HBV genotype D (21.3%) was the predominant circulating genotype, followed by genotypes C (17.2%), E (15.6%), C/D (13.1%), and C/E (10.7%). Genotypes C/D/E (7.4%), A/D (4.9%), D/E (4.1%), A (2.5%), and B, A/E, B/E, and A/D/C (0.8%) were also present. HBV in Eritrea is comprised of a mixture of HBV genotypes. This is the first study of HBV genotyping among patients with liver disease in Eritrea. |
format |
article |
author |
Mohammed Elfatih Hamida Saud Mohammed Raja Yodahi Petros Munir Wahab Yemane Seyoum Isam Mohammed Elkhidir Freweini Tekle |
author_facet |
Mohammed Elfatih Hamida Saud Mohammed Raja Yodahi Petros Munir Wahab Yemane Seyoum Isam Mohammed Elkhidir Freweini Tekle |
author_sort |
Mohammed Elfatih Hamida |
title |
Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
title_short |
Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
title_full |
Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
title_fullStr |
Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
title_full_unstemmed |
Prevalence of hepatitis B virus genotypes among patients with liver disease in Eritrea |
title_sort |
prevalence of hepatitis b virus genotypes among patients with liver disease in eritrea |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/f0e15a3df3ec4269833fbf6db6030b56 |
work_keys_str_mv |
AT mohammedelfatihhamida prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT saudmohammedraja prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT yodahipetros prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT munirwahab prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT yemaneseyoum prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT isammohammedelkhidir prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea AT freweinitekle prevalenceofhepatitisbvirusgenotypesamongpatientswithliverdiseaseineritrea |
_version_ |
1718379322711998464 |